Clinical Trial Update: Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) [NA]

View source ↗

Summary

The PRESERVE trial, sponsored by the University Health Network in Toronto, is evaluating partial breast re-irradiation using ultra-hypofractionation for breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer Recurrent

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Cancer, Breast Cancer Recurrent | NA | Status: RECRUITING